Viewing Study NCT00559702


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-04-11 @ 9:16 AM
Study NCT ID: NCT00559702
Status: COMPLETED
Last Update Posted: 2014-09-09
First Post: 2007-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
Sponsor: Biogen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module